Press release
Postoperative Pain Pipeline Assessment (2023 Updates) | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Competitive Landscape, Treatment Outlook, and Key Companies
Currently, some of the key pharma and biotech giants such as Taiwan Liposome Company (TLC), Teikoku Pharma USA, Novartis Pharmaceuticals, Concentric Analgesics, Mati Therapeutics, Arthritis Innovation Corporation, MedinCell, Surface Ophthalmics, Salvat Laboratories, Grünenthal, Vertex Pharmaceuticals, Formosa Pharmaceuticals, Oculis, Neumentum Pharmaceuticals, Charleston Laboratories, and others are actively working in the Postoperative Pain therapeutics market.
"Postoperative Pain Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Postoperative Pain Therapeutics Market.
The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Postoperative Pain Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing therapies in the Postoperative Pain Market.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postoperative Pain treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Postoperative Pain market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Learn More about the Clinical and Commercial Development Activities in the Postoperative Pain Therapeutics Domain:
https://www.delveinsight.com/report-store/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
Postoperative Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical
Molecule Type
Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Postoperative Pain Therapeutics Analysis
Several major pharma and biotech companies are developing the therapies for Postoperative Pain. Currently, Vivozon is leading the therapeutics market with its Postoperative Pain drug candidates in the most advanced stage of clinical development.
The Leading Players in the Postoperative Pain Therapeutics Market Include:
ACADIA Pharmaceuticals, Adynxx, Apsen Farmaceutica, Arthritis Innovation Corporation, Cali Pharmaceuticals, Charleston Laboratories, Concentric Analgesics, Cytogel, Flexion Therapeutics, Formosa Pharmaceuticals, Grünenthal, Haisco Pharmaceutical Group, Hefei Cosource Pharmaceutical, Jiangsu Hengrui Medicine, Layerbio, Mati Therapeutics, McNeil Consumer Pharmaceuticals, MedinCell, Mylan, Nang Kuang Pharmaceutical, Neumentum Pharmaceuticals, NeurOp, Nevakar, Novartis, Novartis Pharmaceuticals, Oculis Pharma, PainReform, Salvat, Salvat Laboratories, Shijiazhuang Yiling Pharmaceutical, SiteOne Therapeutics, Surface Ophthalmics, Taiwan Liposome Company, Teikoku Pharma USA, Trevena, Unither Pharmaceuticals, Vertex Pharmaceuticals, Vivozon, Xgene Pharmaceutical, and others.
Postoperative Pain Emerging and Marketed Drugs Covered in the Report Include:
• ACP-044: ACADIA Pharmaceuticals
• CAM2048: Camurus
• CYT-1010: Cytogel Pharma
• DEXTENZA (dexamethasone): Ocular Therapeutix
• Qutenza: Grunenthal
• ST 2427: SiteOne Therapeutics
• SVT-15473 (clobetasol propionate ophthalmic nanoemulsion 0.05%): Salvat Laboratories
• TLC590: Taiwan Liposome Company
• VVZ-149: Vivozon
• ZYNRELEF (bupivacaine and meloxicam): Heron Therapeutics
And Many More
Get an in-depth Assessment of the Emerging Therapies and Key Companies:
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Postoperative Pain Current Treatment Patterns
4. Postoperative Pain - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Postoperative Pain Late-Stage Products (Phase-III)
7. Postoperative Pain Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Postoperative Pain Discontinued Products
13. Postoperative Pain Product Profiles
14. Postoperative Pain Key Companies
15. Postoperative Pain Key Products
16. Dormant and Discontinued Products
17. Postoperative Pain Unmet Needs
18. Postoperative Pain Future Perspectives
19. Postoperative Pain Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postoperative Pain Pipeline Assessment (2023 Updates) | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Competitive Landscape, Treatment Outlook, and Key Companies here
News-ID: 3018764 • Views: …
More Releases from DelveInsight Business Research LLP
Glioblastoma Market Size in the 7MM is approximately USD XX Million in 2023, est …
The Glioblastoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2034). Furthermore, launching various multiple- Glioblastoma pipeline products will significantly revolutionize the Glioblastoma market dynamics"
The Glioblastoma market report provides current treatment practices, Glioblastoma emerging drugs, market share of individual therapies, and current and forecasted 7MM Glioblastoma market size from 2020 to 2034. The report also covers current Glioblastoma treatment market practices/algorithms…
Chronic Hepatitis B Market Size was approximately USD 1,500 Million in 2022, est …
"The Chronic Hepatitis B market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2034). Furthermore, launching various multiple- Chronic Hepatitis B pipeline products will significantly revolutionize the Chronic Hepatitis B market dynamics"
The Chronic Hepatitis B market report provides current treatment practices, Chronic Hepatitis B emerging drugs, market share of individual therapies, and current and forecasted 7MM a Chronic Hepatitis B market size…
Alopecia Areata Pipeline, Clinical Trials Assessment, and FDA Approvals 2024 (Up …
DelveInsight's, "Alopecia Areata Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Alopecia Areata pipeline landscape. It covers the Alopecia Areata pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Alopecia Areata Pipeline Report
•…
Plaque Psoriasis Pipeline Insights, FDA Approvals, Clinical Trials Assessment, a …
DelveInsight's, "Plaque Psoriasis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Plaque Psoriasis pipeline landscape. It covers the Plaque Psoriasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Plaque Psoriasis Pipeline Report
•…
More Releases for Pain
Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,…
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big…
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy.
Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have…
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Global Post-operative Pain Management Market - Overview
Post-operative pain management is the most important part…
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in…
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and…
